de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, et al. Reply to: 'Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma'. J Hepatol 2022 May 5. pii: S0168-8278(22)00265.
PMID: 35526788